These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16529810)

  • 21. Combination Strategy with Complexation Hydrogels and Cell-Penetrating Peptides for Oral Delivery of Insulin.
    Fukuoka Y; Khafagy ES; Goto T; Kamei N; Takayama K; Peppas NA; Takeda-Morishita M
    Biol Pharm Bull; 2018; 41(5):811-814. PubMed ID: 29709919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastrointestinal transit and mucoadhesive characteristics of complexation hydrogels in rats.
    Goto T; Morishita M; Kavimandan NJ; Takayama K; Peppas NA
    J Pharm Sci; 2006 Feb; 95(2):462-9. PubMed ID: 16381013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
    Yin L; Ding J; He C; Cui L; Tang C; Yin C
    Biomaterials; 2009 Oct; 30(29):5691-700. PubMed ID: 19615735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biocompatibility of PEG-based hydrogels in primate brain.
    Bjugstad KB; Redmond DE; Lampe KJ; Kern DS; Sladek JR; Mahoney MJ
    Cell Transplant; 2008; 17(4):409-15. PubMed ID: 18522243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of the cytotoxicity and insulin transport of acrylic-based copolymer protein delivery systems in contact with Caco-2 cultures.
    Foss AC; Peppas NA
    Eur J Pharm Biopharm; 2004 May; 57(3):447-55. PubMed ID: 15093592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo evaluation of a novel oral insulin formulation.
    Ma EL; Ma H; Liu Z; Zheng GX; Duan MX
    Acta Pharmacol Sin; 2006 Oct; 27(10):1382-8. PubMed ID: 17007747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges and advances in nanoparticle-based oral insulin delivery.
    Ramesan RM; Sharma CP
    Expert Rev Med Devices; 2009 Nov; 6(6):665-76. PubMed ID: 19911877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel polyelectrolyte complexes based on poly(methacrylic acid)-bis(2-aminopropyl)poly(ethylene glycol) for oral protein delivery.
    Sajeesh S; Sharma CP
    J Biomater Sci Polym Ed; 2007; 18(9):1125-39. PubMed ID: 17931503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A thermosensitive hydrogel based on quaternized chitosan and poly(ethylene glycol) for nasal drug delivery system.
    Wu J; Wei W; Wang LY; Su ZG; Ma GH
    Biomaterials; 2007 Apr; 28(13):2220-32. PubMed ID: 17291582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of archaeosomes as carriers for oral delivery of peptides.
    Li Z; Chen J; Sun W; Xu Y
    Biochem Biophys Res Commun; 2010 Apr; 394(2):412-7. PubMed ID: 20226174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel pH responsive polymethacrylic acid-chitosan-polyethylene glycol nanoparticles for oral peptide delivery.
    Sajeesh S; Sharma CP
    J Biomed Mater Res B Appl Biomater; 2006 Feb; 76(2):298-305. PubMed ID: 16130147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery.
    Sonaje K; Lin YH; Juang JH; Wey SP; Chen CT; Sung HW
    Biomaterials; 2009 Apr; 30(12):2329-39. PubMed ID: 19176244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemically controlled closed-loop insulin delivery.
    Ravaine V; Ancla C; Catargi B
    J Control Release; 2008 Nov; 132(1):2-11. PubMed ID: 18782593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiproteolytic action of orally delivered insulin using pH-responsive hydrogels in a rat burn model.
    Madihally SV; Pantelogianis A; Toner M
    J Surg Res; 2006 Sep; 135(1):187-94. PubMed ID: 16616764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and characterization of cyclic acetal based degradable hydrogels.
    Kaihara S; Matsumura S; Fisher JP
    Eur J Pharm Biopharm; 2008 Jan; 68(1):67-73. PubMed ID: 17888640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Release behavior of amoxicillin from glycol chitosan superporous hydrogels.
    Park J; Kim D
    J Biomater Sci Polym Ed; 2009; 20(5-6):853-62. PubMed ID: 19323894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium phosphate-PEG-insulin-casein (CAPIC) particles as oral delivery systems for insulin.
    Morçöl T; Nagappan P; Nerenbaum L; Mitchell A; Bell SJ
    Int J Pharm; 2004 Jun; 277(1-2):91-7. PubMed ID: 15158972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poly(MAA-co-AN) hydrogels with improved mechanical properties for theophylline controlled delivery.
    Luo Y; Zhang K; Wei Q; Liu Z; Chen Y
    Acta Biomater; 2009 Jan; 5(1):316-27. PubMed ID: 18723415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
    Rekha MR; Sharma CP
    J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of polymer architecture on the protective effect of novel comb shaped amphiphilic poly(allylamine) against in vitro enzymatic degradation of insulin--towards oral insulin delivery.
    Thompson CJ; Tetley L; Cheng WP
    Int J Pharm; 2010 Jan; 383(1-2):216-27. PubMed ID: 19766178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.